Jennifer K. Moses G1 Therapeutics, Inc. (GTHX) insider trading activity

Jennifer K. Moses is CFO of G1 Therapeutics, Inc.. Currently has a direct ownership of 57,820 shares of GTHX, which is worth approximately $413,413. The most recent transaction as insider was on Jan 05, 2023, when has been sold 729 shares (Common Stock) at a price of $5.41 per share, resulting in proceeds of $3,943. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 57.8K

0% 3M change

0% 12M change

Total Value Held $413,413

Jennifer K. Moses Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 05 2023	SELL Open market or private sale	$3,943 $5.41 p/Share	729 Reduced 1.25%	57,820 Common Stock
Jan 04 2023	SELL Open market or private sale	$9,145 $5.58 p/Share	1,639 Reduced 2.72%	58,549 Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	22,300 Added 27.03%	60,188 Common Stock
Feb 01 2022	BUY Exercise of conversion of derivative security	$9,215 $3.95 p/Share	2,333 Added 5.8%	37,888 Common Stock
Jan 05 2022	SELL Open market or private sale	$15,331 $10.61 p/Share	1,445 Reduced 3.91%	35,555 Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	-	12,000 Added 24.49%	37,000 Common Stock
Mar 03 2021	BUY Exercise of conversion of derivative security	$11,160 $3.72 p/Share	3,000 Added 10.71%	25,000 Common Stock
Jan 04 2021	BUY Grant, award, or other acquisition	-	11,000 Added 33.33%	22,000 Common Stock

Also insider at

VRDN

Viridian Therapeutics, Inc.\DE Healthcare

JKM

Jennifer K. Moses

CFO

Research Triangle Park, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GTHX shares.

Notify only if

Value

Insider Trading

Get notified when an G1 Therapeutics, Inc. insider buys or sells GTHX shares.

Notify only if

Operation

Value

Type

News

Receive news related to G1 Therapeutics, Inc.

Track Activities on GTHX

Account